Home
>
National Drug Code (NDC)
>
Cyclophosphamide
Cyclophosphamide - 10019-955-01 - (cyclophosphamide)
Drug Information of Cyclophosphamide
| Product NDC: | 10019-955 |
| Proprietary Name: | Cyclophosphamide |
| Non Proprietary Name: | cyclophosphamide |
| Active Ingredient(s): | 500 mg/25mL & nbsp; cyclophosphamide |
| Administration Route(s): | INTRAVENOUS; ORAL |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cyclophosphamide
| Product NDC: | 10019-955 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040745 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080521 |
Package Information of Cyclophosphamide
| Package NDC: | 10019-955-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-955-01) > 25 mL in 1 VIAL, SINGLE-DOSE (10019-955-50) |
NDC Information of Cyclophosphamide
| NDC Code | 10019-955-01 |
| Proprietary Name | Cyclophosphamide |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-955-01) > 25 mL in 1 VIAL, SINGLE-DOSE (10019-955-50) |
| Product NDC | 10019-955 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cyclophosphamide |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS; ORAL |
| Start Marketing Date | 20080521 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | CYCLOPHOSPHAMIDE |
| Strength Number | 500 |
| Strength Unit | mg/25mL |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
